Yükleniyor... / Loading...
This study examines the use of Ropivacaine in a TQL-block for pain control in patients undergoing laparoscopic or robot-assisted bowel surgery for colon cancer. Eligible patients are over 18 years old and scheduled for this surgery due to colon cancer. It was conducted in Phase 4 and has been completed.
The summary above is a plain-language rendering of the official record. The original English title is shown for reference.
Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.
Inclusion Criteria: * Age \> 18 * Scheduled for laparoscopic or robot assisted hemicolectomy or sigmoidectomy due to colon cancer * Have received thorough information, oral and written, and signed the "Informed Consent" form on participation in the trial * American Society of Anaesthesiologist physical status classification, class 1-3 Exclusion Criteria: * Inability to cooperate * Inability to speak and understand Danish * Allergy to local anaesthetics or opioids * Daily intake of opioids (evaluated by the investigators) * Drug and/or substance abuse * Local infection at the site of injection or systemic infection * Difficulty visualisation of muscular and fascial structures in ultrasound visualisation necessary to the block administration * Pregnant\* or breastfeeding * Daily use of oral or intravenous steroids * Known immune deficiency (evaluated by the investigators) * Other simultaneous or previous cancer diagnosis (except non-melanoma skin cancer) within the last five years (within the last five years added 28th nov 2019 after ethics committee approval).